OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
AGA Clinical Practice Guideline on Pharmacological Interventions for Adults With Obesity
Eduardo Grunvald, Raj Shah, Rubén Hernáez, et al.
Gastroenterology (2022) Vol. 163, Iss. 5, pp. 1198-1225
Open Access | Times Cited: 144
Eduardo Grunvald, Raj Shah, Rubén Hernáez, et al.
Gastroenterology (2022) Vol. 163, Iss. 5, pp. 1198-1225
Open Access | Times Cited: 144
Showing 1-25 of 144 citing articles:
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
Frank Tacke, Paul Horn, Vincent Wai–Sun Wong, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 3, pp. 492-542
Closed Access | Times Cited: 332
Frank Tacke, Paul Horn, Vincent Wai–Sun Wong, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 3, pp. 492-542
Closed Access | Times Cited: 332
Obesity Management in Adults
Arielle Elmaleh-Sachs, Jessica L. Schwartz, Carolyn T. Bramante, et al.
JAMA (2023) Vol. 330, Iss. 20, pp. 2000-2000
Open Access | Times Cited: 229
Arielle Elmaleh-Sachs, Jessica L. Schwartz, Carolyn T. Bramante, et al.
JAMA (2023) Vol. 330, Iss. 20, pp. 2000-2000
Open Access | Times Cited: 229
EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Frank Tacke, Paul Horn, Vincent Wai–Sun Wong, et al.
Obesity Facts (2024) Vol. 17, Iss. 4, pp. 374-444
Open Access | Times Cited: 62
Frank Tacke, Paul Horn, Vincent Wai–Sun Wong, et al.
Obesity Facts (2024) Vol. 17, Iss. 4, pp. 374-444
Open Access | Times Cited: 62
Obesity and diabetes
Chrysoula Boutari, Antea DeMarsilis, Christos S. Mantzoros
Diabetes Research and Clinical Practice (2023) Vol. 202, pp. 110773-110773
Closed Access | Times Cited: 57
Chrysoula Boutari, Antea DeMarsilis, Christos S. Mantzoros
Diabetes Research and Clinical Practice (2023) Vol. 202, pp. 110773-110773
Closed Access | Times Cited: 57
Natural products as novel anti-obesity agents: insights into mechanisms of action and potential for therapeutic management
Ummul Fathima Shaik Mohamed Sayed, Said Moshawih, Hui Poh Goh, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 53
Ummul Fathima Shaik Mohamed Sayed, Said Moshawih, Hui Poh Goh, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 53
Obesity and its comorbidities, current treatment options and future perspectives: Challenging bariatric surgery?
Simon Kloock, Christian G. Ziegler, Ulrich Dischinger
Pharmacology & Therapeutics (2023) Vol. 251, pp. 108549-108549
Open Access | Times Cited: 51
Simon Kloock, Christian G. Ziegler, Ulrich Dischinger
Pharmacology & Therapeutics (2023) Vol. 251, pp. 108549-108549
Open Access | Times Cited: 51
Medications for Obesity
Kimberly A. Gudzune, Robert F. Kushner
JAMA (2024) Vol. 332, Iss. 7, pp. 571-571
Closed Access | Times Cited: 50
Kimberly A. Gudzune, Robert F. Kushner
JAMA (2024) Vol. 332, Iss. 7, pp. 571-571
Closed Access | Times Cited: 50
Obesity: A Review of Pathophysiology and Classification
Bradley Busebee, Wissam Ghusn, Lizeth Cifuentes, et al.
Mayo Clinic Proceedings (2023) Vol. 98, Iss. 12, pp. 1842-1857
Open Access | Times Cited: 49
Bradley Busebee, Wissam Ghusn, Lizeth Cifuentes, et al.
Mayo Clinic Proceedings (2023) Vol. 98, Iss. 12, pp. 1842-1857
Open Access | Times Cited: 49
Effectiveness and safety of drugs for obesity
Kristina H. Lewis, Caroline E Sloan, Daniel H. Bessesen, et al.
BMJ (2024), pp. e072686-e072686
Open Access | Times Cited: 25
Kristina H. Lewis, Caroline E Sloan, Daniel H. Bessesen, et al.
BMJ (2024), pp. e072686-e072686
Open Access | Times Cited: 25
GLP-1 agonists: A review for emergency clinicians
Brit Long, Jessica Pelletier, Alex Koyfman, et al.
The American Journal of Emergency Medicine (2024) Vol. 78, pp. 89-94
Closed Access | Times Cited: 24
Brit Long, Jessica Pelletier, Alex Koyfman, et al.
The American Journal of Emergency Medicine (2024) Vol. 78, pp. 89-94
Closed Access | Times Cited: 24
Review article: Pharmacologic management of obesity ‐ updates on approved medications, indications and risks
Camille Lupiañez-Merly, Saam Dilmaghani, Kia Vosoughi, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 59, Iss. 4, pp. 475-491
Closed Access | Times Cited: 18
Camille Lupiañez-Merly, Saam Dilmaghani, Kia Vosoughi, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 59, Iss. 4, pp. 475-491
Closed Access | Times Cited: 18
Approach to Obesity Treatment in Primary Care
Susan Z. Yanovski, Jack A. Yanovski
JAMA Internal Medicine (2024) Vol. 184, Iss. 7, pp. 818-818
Closed Access | Times Cited: 14
Susan Z. Yanovski, Jack A. Yanovski
JAMA Internal Medicine (2024) Vol. 184, Iss. 7, pp. 818-818
Closed Access | Times Cited: 14
American Society for Gastrointestinal Endoscopy–European Society of Gastrointestinal Endoscopy guideline on primary endoscopic bariatric and metabolic therapies for adults with obesity
Pichamol Jirapinyo, Alia Hadefi, Vincent Huberty, et al.
Endoscopy (2024) Vol. 56, Iss. 06, pp. 437-456
Open Access | Times Cited: 14
Pichamol Jirapinyo, Alia Hadefi, Vincent Huberty, et al.
Endoscopy (2024) Vol. 56, Iss. 06, pp. 437-456
Open Access | Times Cited: 14
Evidence for a causal link between intra-pancreatic fat deposition and pancreatic cancer: A prospective cohort and Mendelian randomization study
Hajime Yamazaki, Samantha A. Streicher, Lang Wu, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 2, pp. 101391-101391
Open Access | Times Cited: 12
Hajime Yamazaki, Samantha A. Streicher, Lang Wu, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 2, pp. 101391-101391
Open Access | Times Cited: 12
Role of lifestyle and glucagon‐like peptide‐1 receptor agonists for weight loss in obesity, type 2 diabetes and steatotic liver diseases
Anna Giannakogeorgou, Michael Roden
Alimentary Pharmacology & Therapeutics (2024) Vol. 59, Iss. S1
Open Access | Times Cited: 12
Anna Giannakogeorgou, Michael Roden
Alimentary Pharmacology & Therapeutics (2024) Vol. 59, Iss. S1
Open Access | Times Cited: 12
Inequalities in the provision of GLP-1 receptor agonists for the treatment of obesity
Stephanie W. Waldrop, Veronica R. Johnson, Fatima Cody Stanford
Nature Medicine (2024) Vol. 30, Iss. 1, pp. 22-25
Closed Access | Times Cited: 11
Stephanie W. Waldrop, Veronica R. Johnson, Fatima Cody Stanford
Nature Medicine (2024) Vol. 30, Iss. 1, pp. 22-25
Closed Access | Times Cited: 11
Emerging evidence for glucagon-like peptide-1 agonists in slowing chronic kidney disease progression
Michael W. Holliday, Livia Frost, Sankar D. Navaneethan
Current Opinion in Nephrology & Hypertension (2024) Vol. 33, Iss. 3, pp. 331-336
Closed Access | Times Cited: 10
Michael W. Holliday, Livia Frost, Sankar D. Navaneethan
Current Opinion in Nephrology & Hypertension (2024) Vol. 33, Iss. 3, pp. 331-336
Closed Access | Times Cited: 10
Overweight and Obesity
Sarah J. Miller, Sherrill Brown
The American Pharmacists Association eBooks (2024)
Closed Access | Times Cited: 9
Sarah J. Miller, Sherrill Brown
The American Pharmacists Association eBooks (2024)
Closed Access | Times Cited: 9
Emerging Pharmacotherapies for Obesity: A Systematic Review
Michail Kokkorakis, Marlene Chakhtoura, Caline Rhayem, et al.
Pharmacological Reviews (2024) Vol. 77, Iss. 1, pp. 100002-100002
Open Access | Times Cited: 9
Michail Kokkorakis, Marlene Chakhtoura, Caline Rhayem, et al.
Pharmacological Reviews (2024) Vol. 77, Iss. 1, pp. 100002-100002
Open Access | Times Cited: 9
Focused Recommendations for the Management of Metabolic Dysfunction-Associated Steatohepatitis (MASH) by Advanced Practice Providers in the United States
Brian Lam, Jessica Bartholomew, Sherona Bau, et al.
Journal of Clinical Gastroenterology (2025)
Closed Access | Times Cited: 1
Brian Lam, Jessica Bartholomew, Sherona Bau, et al.
Journal of Clinical Gastroenterology (2025)
Closed Access | Times Cited: 1
Incidence of metabolic and bariatric surgery among US adults with obesity by diabetes status: 2016–2020
Yiling J. Cheng, Kai McKeever Bullard, Israel Hora, et al.
BMJ Open Diabetes Research & Care (2025) Vol. 13, Iss. 1, pp. e004614-e004614
Open Access | Times Cited: 1
Yiling J. Cheng, Kai McKeever Bullard, Israel Hora, et al.
BMJ Open Diabetes Research & Care (2025) Vol. 13, Iss. 1, pp. e004614-e004614
Open Access | Times Cited: 1
Novel Antidiabetic Drugs and Risk of Venous Thromboembolism: A Literature Review
Qingui Chen, Rayna J.S. Anijs, Judith P.L. Verlaan, et al.
Seminars in Thrombosis and Hemostasis (2025)
Closed Access | Times Cited: 1
Qingui Chen, Rayna J.S. Anijs, Judith P.L. Verlaan, et al.
Seminars in Thrombosis and Hemostasis (2025)
Closed Access | Times Cited: 1
Impact of medical versus surgical weight loss on cardiovascular outcomes
Alexander Ostapenko, Bestoun Ahmed
Trends in Cardiovascular Medicine (2025)
Closed Access | Times Cited: 1
Alexander Ostapenko, Bestoun Ahmed
Trends in Cardiovascular Medicine (2025)
Closed Access | Times Cited: 1
Real‐world evidence on the utilization, clinical and comparative effectiveness, and adverse effects of newer GLP ‐1RA ‐based weight‐loss therapies
Reimar W. Thomsen, Aurélie Mailhac, Julie B. Løhde, et al.
Diabetes Obesity and Metabolism (2025)
Open Access | Times Cited: 1
Reimar W. Thomsen, Aurélie Mailhac, Julie B. Løhde, et al.
Diabetes Obesity and Metabolism (2025)
Open Access | Times Cited: 1
Cost-effectiveness of endoscopic, surgical and pharmacological obesity therapies: a microsimulation and threshold analyses
Monica Saumoy, Devika Gandhi, Seth Buller, et al.
Gut (2023) Vol. 72, Iss. 12, pp. 2250-2259
Closed Access | Times Cited: 21
Monica Saumoy, Devika Gandhi, Seth Buller, et al.
Gut (2023) Vol. 72, Iss. 12, pp. 2250-2259
Closed Access | Times Cited: 21
